TRIPS and global pharmaceutical industry
Subtitle: perspectives and implications
By: edited by Manish Ashiya
Edition: 1st ed.
Publisher: Icfai University Press
Published: 2007
Place of publication: Hyderabad, India
Language: eng
Number of pages: 215
ISBN-13: 9788131406243
Subjects: Drugs; Patents; Law and legislation; Intellectual property (International law); Public health laws; Agreement on Trade-Related Aspects of Intellectual Property Rights
Other titles: Trade Related Intellectual Property Rights and global pharmaceutical industry
Notes: Contributed articles; most previously published.

"Icfai books."

Includes bibliographical references and index.
Table of contents: title: Globalisation, health and foreign policy : emerging linkages and interests  -- John Wyn Owen and Olivia Roberts; title: Trade and health : is the health community ready for action?  -- Kelley Lee and Meri Koivusalo; title: TRIPS and health --; title: Agreement on IPR relating to trade and pharmaceutical patents --; title: Africa regional workshop on WTO negotiations  -- Tenu Avafia; title: TRIPS flexibilities : a critical review  -- Vishwas H. Devaiah; title: Access to medicines --; title: Health and intellectual property rights : thoughts on ensuring access to medicines in 2005 and beyond  -- Karin Timmermnas; title: Counterfeit medicines in less developed countries ; problems and solutions  -- Julian Morris and Philip Stevens; title: Data exclusivity : the implications for India  -- Alfred Adebare; title: Adaptive innovation, intellectual property and the public interest : how patent extension leads to more, better and safer medicines  -- William Looney; title: Ten years later : U.S. report on IPR compliance still questioned  -- William New; title: Medical research and development treaty : a new R&D framework  -- Manish Ashiya and Anu Jindal; title: Creating and promoting domestic drug manufacturing capacities : legal and economic feasibility assessment  -- Juan Rovira; title: IPR and protection of traditional medicine  -- Anu Jindal; title: Generic drug companies : competing at boundaries of time and geography -- Michael Gollin.